A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.
第一作者:
James G,Christensen
第一单位:
Preclinical Research and Exploratory Development, SUGEN, Inc., South San Francisco, CA 94080, USA. james.christensen@pfizer.com
作者:
医学主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系(Cell Line);细胞系, 肿瘤(Cell Line, Tumor);狗(Dogs);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);酶抑制剂(Enzyme Inhibitors);女(雌)性(Female);人类(Humans);吲哚类(Indoles);肾(Kidney);动力学(Kinetics);肺肿瘤(Lung Neoplasms);小鼠(Mice);小鼠, 裸(Mice, Nude);NIH 3T3细胞(NIH 3T3 Cells);胰腺肿瘤(Pancreatic Neoplasms);磷酰化(Phosphorylation);原癌基因蛋白质c-met(Proto-Oncogene Proteins c-met);大鼠(Rats);信号传导(Signal Transduction);胃肿瘤(Stomach Neoplasms);砜类(Sulfones);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
PMID
14612533
发布时间
2009-11-19
- 浏览13
Cancer research
7345-55页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



